Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H C Post

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Cancer Policy|June 7, 2024
The narrow road to expanded accessH C Post, T Schutte, J Voortman, et al.
ESMO Open|April 8, 2023
Time to reimbursement of novel anticancer drugs in Europe: a case study of seven European countriesH C Post, T Schutte, M G H van Oijen, et al.
The Oncologist|February 25, 2026
Cost implications of early treatment discontinuation in cancer: a real-world data analysisH C Post, K Opmeer, T Schutte, et al.
ESMO Open|November 13, 2025
Access to anticancer and orphan medicines through compassionate use programs and named patient basis in seven European countriesN Rosenberg, H C Post, T Schutte, et al.
Journal of Medical Case Reports|October 4, 2022
Painful lower limb nodules as first symptom of resectable pancreatic acinar cell cancer: a case reportS M Haenen, J A M G Tol, S C J van Steen, et al.
Eclinicalmedicine|October 2, 2023
Effect of a prediction tool and communication skills training on communication of treatment outcomes: a multicenter stepped wedge clinical trial (the SOURCE trial)L F van de Water, S C Kuijper, I Henselmans, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Cancer Policy|June 7, 2024
The narrow road to expanded accessH C Post, T Schutte, J Voortman, et al.
ESMO Open|April 8, 2023
Time to reimbursement of novel anticancer drugs in Europe: a case study of seven European countriesH C Post, T Schutte, M G H van Oijen, et al.
The Oncologist|February 25, 2026
Cost implications of early treatment discontinuation in cancer: a real-world data analysisH C Post, K Opmeer, T Schutte, et al.
ESMO Open|November 13, 2025
Access to anticancer and orphan medicines through compassionate use programs and named patient basis in seven European countriesN Rosenberg, H C Post, T Schutte, et al.
Journal of Medical Case Reports|October 4, 2022
Painful lower limb nodules as first symptom of resectable pancreatic acinar cell cancer: a case reportS M Haenen, J A M G Tol, S C J van Steen, et al.
Eclinicalmedicine|October 2, 2023
Effect of a prediction tool and communication skills training on communication of treatment outcomes: a multicenter stepped wedge clinical trial (the SOURCE trial)L F van de Water, S C Kuijper, I Henselmans, et al.
Pageof 1